Literature DB >> 16000420

Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study.

Kim Ekelund1, Jessica Darenberg, Anna Norrby-Teglund, Steen Hoffmann, Didi Bang, Peter Skinhøj, Helle Bossen Konradsen.   

Abstract

Since the late 1980s several studies have described the increased incidence and severity of invasive group A streptococcal (GAS) infections. However, most studies on GAS pathogenesis have focused on information obtained during outbreaks. We analyzed isolate distribution and host susceptibility as part of a nationwide prospective surveillance study performed between January 2001 and August 2002. GAS isolates collected from 201 patients with invasive infections, 335 patients with noninvasive infections, and 17 asymptomatic carriers were characterized with respect to their emm types and superantigen genotypes. The superantigen-neutralizing capacity and levels of antibodies against streptolysin O and DNAse B were determined for isolates from the sera from 36 invasive cases and 91 noninvasive cases. emm type 1 (emm-1) isolates were significantly more common among invasive cases, whereas emm-4, emm-6, and emm-12 dominated among the noninvasive cases. The distributions of the phage-associated superantigen genes (speA, speC, speH, speI, ssa) differed among invasive and noninvasive isolates, mainly due to their linkage to certain emm types. No significant differences in serum superantigen-neutralizing capacities were observed. The levels of anti-streptolysin O and anti-DNAse B antibodies were highest in the sera from invasive cases. Our study emphasizes the importance of obtaining data during years with stable incidences, which will enable evaluation of future outbreak data.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16000420      PMCID: PMC1169105          DOI: 10.1128/JCM.43.7.3101-3109.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  40 in total

1.  Unusual occurrence of M type 77, antibiotic-resistant group A streptococci in southern Sweden.

Authors:  A Jasir; A Tanna; A Efstratiou; C Schalén
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  Immunological and biochemical characterization of streptococcal pyrogenic exotoxins I and J (SPE-I and SPE-J) from Streptococcus pyogenes.

Authors:  T Proft; V L Arcus; V Handley; E N Baker; J D Fraser
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

3.  Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci.

Authors:  B Beall; R Facklam; T Thompson
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

4.  Contrasting molecular epidemiology of group A streptococci causing tropical and nontropical infections of the skin and throat.

Authors:  D E Bessen; J R Carapetis; B Beall; R Katz; M Hibble; B J Currie; T Collingridge; M W Izzo; D A Scaramuzzino; K S Sriprakash
Journal:  J Infect Dis       Date:  2000-09-08       Impact factor: 5.226

5.  Evidence for superantigen involvement in severe group a streptococcal tissue infections.

Authors:  A Norrby-Teglund; P Thulin; B S Gan; M Kotb; A McGeer; J Andersson; D E Low
Journal:  J Infect Dis       Date:  2001-08-15       Impact factor: 5.226

6.  Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases.

Authors:  S Chatellier; N Ihendyane; R G Kansal; F Khambaty; H Basma; A Norrby-Teglund; D E Low; A McGeer; M Kotb
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

Review 7.  Group A streptococci in the 1990s.

Authors:  A Efstratiou
Journal:  J Antimicrob Chemother       Date:  2000-02       Impact factor: 5.790

8.  Opsonization of T1M1 group A Streptococcus: dynamics of antibody production and strain specificity.

Authors:  B K Eriksson; A Villasenor-Sierra; M Norgren; D L Stevens
Journal:  Clin Infect Dis       Date:  2001-01-15       Impact factor: 9.079

9.  Functional characterization of streptococcal pyrogenic exotoxin J, a novel superantigen.

Authors:  J K McCormick; A A Pragman; J C Stolpa; D Y Leung; P M Schlievert
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

10.  emm typing and validation of provisional M types for group A streptococci.

Authors:  R Facklam; B Beall; A Efstratiou; V Fischetti; D Johnson; E Kaplan; P Kriz; M Lovgren; D Martin; B Schwartz; A Totolian; D Bessen; S Hollingshead; F Rubin; J Scott; G Tyrrell
Journal:  Emerg Infect Dis       Date:  1999 Mar-Apr       Impact factor: 6.883

View more
  23 in total

1.  Invasive group A streptococcal infections.

Authors:  Erica Weir; Cheryl Main
Journal:  CMAJ       Date:  2006-07-04       Impact factor: 8.262

2.  Nonoutbreak surveillance of group A streptococci causing invasive disease in Portugal identified internationally disseminated clones among members of a genetically heterogeneous population.

Authors:  A Friães; M Ramirez; J Melo-Cristino
Journal:  J Clin Microbiol       Date:  2007-04-25       Impact factor: 5.948

3.  Rapid emergence of emm84 among invasive Streptococcus pyogenes infections in Finland.

Authors:  Tuula Siljander; Outi Lyytikäinen; Susanna Vähäkuopus; Petrus Säilä; Jari Jalava; Jaana Vuopio-Varkila
Journal:  J Clin Microbiol       Date:  2008-12-10       Impact factor: 5.948

4.  Streptococcus pyogenes bacteraemia, emm types and superantigen profiles.

Authors:  S Rantala; S Vähäkuopus; T Siljander; J Vuopio; H Huhtala; R Vuento; J Syrjänen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-30       Impact factor: 3.267

5.  Therapeutic failures of antibiotics used to treat macrolide-susceptible Streptococcus pyogenes infections may be due to biofilm formation.

Authors:  Lucilla Baldassarri; Roberta Creti; Simona Recchia; Monica Imperi; Bruna Facinelli; Eleonora Giovanetti; Marco Pataracchia; Giovanna Alfarone; Graziella Orefici
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

6.  Epidemiology, outcome and emm types of invasive group A streptococcal infections in Finland.

Authors:  T Siljander; O Lyytikäinen; S Vähäkuopus; M Snellman; J Jalava; J Vuopio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-20       Impact factor: 3.267

7.  Group A streptococci from invasive-disease episodes in Poland are remarkably divergent at the molecular level.

Authors:  Katarzyna Szczypa; Ewa Sadowy; Radoslaw Izdebski; Lenka Strakova; Waleria Hryniewicz
Journal:  J Clin Microbiol       Date:  2006-09-06       Impact factor: 5.948

8.  Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004.

Authors:  Bogdan Luca-Harari; Kim Ekelund; Mark van der Linden; Margit Staum-Kaltoft; Anette M Hammerum; Aftab Jasir
Journal:  J Clin Microbiol       Date:  2007-10-24       Impact factor: 5.948

9.  emm Types, virulence factors, and antibiotic resistance of invasive Streptococcus pyogenes isolates from Italy: What has changed in 11 years?

Authors:  Roberta Creti; Monica Imperi; Lucilla Baldassarri; Marco Pataracchia; Simona Recchia; Giovanna Alfarone; Graziella Orefici
Journal:  J Clin Microbiol       Date:  2007-05-09       Impact factor: 5.948

10.  Severe Streptococcus pyogenes infections, United Kingdom, 2003-2004.

Authors:  Theresa L Lamagni; Shona Neal; Catherine Keshishian; Neelam Alhaddad; Robert George; Georgia Duckworth; Jaana Vuopio-Varkila; Androulla Efstratiou
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.